Read More Pharma Industry News Incyte secures FDA priority review for pemigatinib in cholangiocarcinoma Delaware-based pharma company Incyte has secured priority review for pemigatinib from the US Food and Drug Administration (FDA)… bypharmanewsdailyDecember 3, 2019
